November 7, 2016
Bayer seeks approval for its liver cancer drug
Bayer on Monday announced the submission of applications to extend the marketing authorization for its oral multi-kinase inhibitor
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Joerg Moeller
October 30, 2015
Bayer’s Eylea approved for Myopic CNV
Eylea is now also approved for the treatment of visual impairment due to myopic choroidal neovascularization (myopic CNV).
September 25, 2015
CHMP reccomends Bayer’s Eye medicine for approval in EU
The European Committee for Medicinal Products for Human Use (CHMP) has recommended Bayer’s aflibercept solution for injection into the eye…